Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M8,854Revenue $M7,146Net Margin (%)11.9Z-Score2.9
Enterprise Value $M12,685EPS $5.5Operating Margin %20.6F-Score5
P/E(ttm))11.1Cash Flow Per Share $5.2Pre-tax Margin (%)18.9Higher ROA y-yY
Price/Book2.210-y EBITDA Growth Rate %8.4Quick Ratio1.2Cash flow > EarningsN
Price/Sales1.35-y EBITDA Growth Rate %6.8Current Ratio1.3Lower Leverage y-yN
Price/Cash Flow11.3y-y EBITDA Growth Rate %30.8ROA % (ttm)9.5Higher Current Ratio y-yY
Dividend Yield %2.1Insider Buy (3m)2ROE % (ttm)21.5Less Shares Outstanding y-yY
Payout Ratio %23.0Shares Outstanding M144ROI % (ttm)5.5Gross Margin Increase y-yN

Gurus Latest Trades with DGX

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DGXDavid Dreman 2014-03-31 Add0.09%$50.8 - $57.99
($53.53)
$ 61.2814%Add 66.84%48,748
DGXRay Dalio 2014-03-31 Buy 0.04%$50.8 - $57.99
($53.53)
$ 61.2814%New holding, 78977 sh.78,977
DGXJoel Greenblatt 2014-03-31 Reduce-0.26%$50.8 - $57.99
($53.53)
$ 61.2814%Reduce -72.63%76,412
DGXJoel Greenblatt 2013-12-31 Add0.3%$52.79 - $63.7
($59.36)
$ 61.283%Add 533.63%279,188
DGXDavid Dreman 2013-12-31 Reduce-0.06%$52.79 - $63.7
($59.36)
$ 61.283%Reduce -28.19%29,218
DGXJoel Greenblatt 2013-09-30 Add0.03%$57.96 - $62.48
($59.81)
$ 61.282%Add 41.25%44,062
DGXRay Dalio 2013-09-30 Sold Out $57.96 - $62.48
($59.81)
$ 61.282%Sold Out0
DGXRay Dalio 2013-06-30 Buy $55.48 - $63.2
($59.57)
$ 61.283%New holding, 4598 sh.4,598
DGXJoel Greenblatt 2013-06-30 Reduce-0.16%$55.48 - $63.2
($59.57)
$ 61.283%Reduce -64.8%31,194
DGXDavid Dreman 2013-03-31 Buy 0.07%$55.42 - $61.83
($57.49)
$ 61.287%New holding, 46116 sh.46,116
DGXJoel Greenblatt 2013-03-31 Add0.06%$55.42 - $61.83
($57.49)
$ 61.287%Add 32.8%88,614
DGXVanguard Health Care Fund 2013-03-31 Sold Out -1%$55.42 - $61.83
($57.49)
$ 61.287%Sold Out0
DGXJoel Greenblatt 2012-12-31 Add0.12%$56.31 - $64.68
($59.32)
$ 61.283%Add 131.43%66,725
DGXJoel Greenblatt 2012-09-30 Reduce-0.08%$57.25 - $63.51
($60.59)
$ 61.281%Reduce -38.41%28,832
DGXJoel Greenblatt 2012-06-30 Add0.08%$53.74 - $61.77
($57.7)
$ 61.286%Add 62.64%46,812
DGXRay Dalio 2012-06-30 Sold Out -0.03%$53.74 - $61.77
($57.7)
$ 61.286%Sold Out0
DGXJoel Greenblatt 2012-03-31 Add0.13%$56.5 - $61.21
($54.81)
$ 61.2812%Add 611.37%28,782
DGXRay Dalio 2012-03-31 Buy 0.03%$56.5 - $61.21
($54.81)
$ 61.2812%New holding, 34998 sh.34,998
DGXJoel Greenblatt 2011-12-31 Reduce-0.06%$46.29 - $59.18
($54.42)
$ 61.2813%Reduce -66.54%4,046
DGXRay Dalio 2011-12-31 Sold Out -0.04%$46.29 - $59.18
($54.42)
$ 61.2813%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DGX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
DGX Ray Dalio 2014-03-3178,9770.050.04New Buy
DGX David Dreman 2014-03-3148,7480.030.22+66.84%
DGX Joel Greenblatt 2014-03-3176,4120.050.07-72.63%
Premium Most recent portfolio changes are included for Premium Members only!


DGX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ZIEGLER JOHN BDirector 2014-05-22Sell2,973$57.655.38view
PFEIFFER GARY MDirector 2014-05-07Sell10,000$55.958.58view
GUINAN MARKSenior Vice President & CFO 2014-05-05Buy4,000$55.519.44view
STANZIONE DANIELDirector 2014-04-30Sell30,000$55.758.97view
PREVOZNIK MICHAEL ESVP & General Counsel 2014-03-04Sell778$5314.62view
BRITELL JENNE KDirector 2014-02-27Sell10,000$52.7415.19view
PREVOZNIK MICHAEL ESVP & General Counsel 2014-02-27Sell827$52.9914.64view
PREVOZNIK MICHAEL ESVP & General Counsel 2014-02-19Sell2,860$52.2616.25view
WILENSKY GAIL RDirector 2014-02-18Sell30,000$52.9314.77view
BUEHLER WILLIAM FDirector 2014-02-12Sell30,000$52.1516.49view

Press Releases about DGX :

    Quarterly/Annual Reports about DGX:

    News about DGX:

    Articles On GuruFocus.com
    Top Five Guru-Owned Mid Cap Stocks Jun 18 2014 
    Morning Coffee: Widely Held Guru Stocks Trading Near Historical Low P/S May 28 2014 
    Morning Coffee: Widely Held Guru Stocks Near Historic Low P/S May 13 2014 
    Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B May 05 2014 
    Morning Coffee: Widely Held Guru Stocks Trading Near Historical Low P/S Apr 29 2014 
    Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B Apr 28 2014 
    Medical Diagnostic Labs Facing Medicare Headwinds Mar 25 2014 
    Morning Coffee: Stocks at Historical Low P/B and P/S Mar 25 2014 
    Diamond Hill Capital Comments on Quest Diagnostics Mar 05 2014 
    It's Time to Follow Chris Davis and Buy Laboratory Corp Jan 15 2014 


    More From Other Websites
    Decline in Prescription Drug Misuse More than Twice as High in States with Broad Drug Abuse... Jul 16 2014
    Decline in Prescription Drug Misuse More than Twice as High in States with Broad Drug Abuse... Jul 16 2014
    Change Agents: Elizabeth Holmes wants your blood Jul 08 2014
    Quest Diagnostics To Release Second Quarter 2014 Financial Results On July 24 Jul 08 2014
    Change Agents: Elizabeth Holmes wants your blood Jul 07 2014
    Quest Diagnostics To Release Second Quarter 2014 Financial Results On July 24 Jul 07 2014
    Bloody Amazing Jul 02 2014
    Why Response Genetics Could Be the Business Cure for Quest Diagnostics Jun 20 2014
    Sequenom Laboratories and Quest Diagnostics Collaborate to Expand Patient Access to the... Jun 16 2014
    Quest Diagnostics Expands with Precision Medicine for Melanoma Jun 11 2014
    Quest Diagnostics Introduces bioMerieux THxID®-BRAF Companion Diagnostic to Advance Precision... Jun 10 2014
    Quest Diagnostics To Speak At The Goldman Sachs 35th Annual Global Healthcare Conference Jun 04 2014
    Trade-Ideas: Quest Diagnostics (DGX) Is Today's "Barbarian At The Gate" Stock Jun 03 2014
    Quest Diagnostics, Memorial Sloan Kettering announce collaboration Jun 01 2014
    Memorial Sloan Kettering Cancer Center and Quest Diagnostics Partner to Advance Precision Medicine... Jun 01 2014
    Quest Joins Memorial Sloan Kettering for Cancer Tests Jun 01 2014
    The Best Dividend Growers, Part 15: Quest Diagnostics May 28 2014
    QUEST DIAGNOSTICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to... May 23 2014
    Quest Diagnostics Declares Quarterly Cash Dividend May 21 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide